Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 6 (2009), Issue 10 (October)

1. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
   J Nucl Med, 50(10): 1700-8. [Abstract] [Full-text]
2. 18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.
   J Nucl Med, 50(10): 1655-65. [Abstract] [Full-text]
3. Validation of the radiosurgery-based arteriovenous malformation score in a large linear accelerator radiosurgery experience.
   J Neurosurg, 111(4): 832-9. [Abstract] [Full-text]
4. The results of resection after stereotactic radiosurgery for brain metastases.
   J Neurosurg, 111(4): 825-31. [Abstract] [Full-text]
5. Failure rate of contemporary low-dose radiosurgical technique for vestibular schwannoma.
   J Neurosurg, 111(4): 840-4. [Abstract] [Full-text]
6. Early results of CyberKnife radiosurgery for arteriovenous malformations.
   J Neurosurg, 111(4): 807-19. [Abstract] [Full-text]
7. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma.
   J Neurosurg, 111(4): 863-73. [Abstract] [Full-text]
8. Radiation-induced meningiomas: a shadow in the success story of childhood leukemia.
   Neuro Oncol, 11(5): 543-9. [Abstract] [Full-text]
9. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
   Int J Radiat Oncol Biol Phys, 75(3): 950-8. [Abstract] [Full-text]
10. Study of robustness of IMPT and IMRT for prostate cancer against organ movement.
    Int J Radiat Oncol Biol Phys, 75(3): 941-9. [Abstract] [Full-text]
11. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT.
    Int J Radiat Oncol Biol Phys, 75(3): 924-32. [Abstract] [Full-text]
12. The PPARalpha agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation.
    Int J Radiat Oncol Biol Phys, 75(3): 870-7. [Abstract] [Full-text]
13. Intensity-modulated radiotherapy optimization in a quasi-periodically deforming patient model.
    Int J Radiat Oncol Biol Phys, 75(3): 906-14. [Abstract] [Full-text]
14. In vitro cytotoxicity of low-dose-rate radioimmunotherapy by the alpha-emitting radioimmunoconjugate Thorium-227-DOTA-rituximab.
    Int J Radiat Oncol Biol Phys, 75(3): 886-95. [Abstract] [Full-text]
15. Percutaneous fluoroscopically guided salvage of misplaced perirectal (125)I prostate seeds-easy way out.
    Urology, 74(4): 924-5. [Abstract] [Full-text]
16. Quantitative assessment of image-guided radiotherapy for paraspinal tumors.
    Int J Radiat Oncol Biol Phys, 75(3): 933-40. [Abstract] [Full-text]
17. Long-term outcome of gamma knife radiosurgery for treatment of typical trigeminal neuralgia.
    Int J Radiat Oncol Biol Phys, 75(3): 822-7. [Abstract] [Full-text]
18. Helical tomotherapy for simultaneous multitarget radiotherapy for pulmonary metastasis.
    Int J Radiat Oncol Biol Phys, 75(3): 703-10. [Abstract] [Full-text]
19. Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography.
    Int J Radiat Oncol Biol Phys, 75(3): 688-95. [Abstract] [Full-text]
20. Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.
    Int J Radiat Oncol Biol Phys, 75(3): 725-33. [Abstract] [Full-text]
21. Stereotactic radiotherapy for locally recurrent nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys, 75(3): 734-41. [Abstract] [Full-text]
22. Preoperative intensity-modulated radiotherapy combined with temozolomide for locally advanced soft-tissue sarcoma.
    Int J Radiat Oncol Biol Phys, 75(3): 810-6. [Abstract] [Full-text]
23. Erectile function durability following permanent prostate brachytherapy.
    Int J Radiat Oncol Biol Phys, 75(3): 639-48. [Abstract] [Full-text]
24. Correlation of point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapy.
    Int J Radiat Oncol Biol Phys, 75(3): 803-9. [Abstract] [Full-text]
25. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.
    Int J Radiat Oncol Biol Phys, 75(3): 677-82. [Abstract] [Full-text]
26. Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
    Int J Radiat Oncol Biol Phys, 75(3): 656-63. [Abstract] [Full-text]
27. Clinical outcome of dose-escalated image-guided radiotherapy for spinal metastases.
    Int J Radiat Oncol Biol Phys, 75(3): 828-35. [Abstract] [Full-text]
28. Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvement.
    Int J Radiat Oncol Biol Phys, 75(3): 791-4. [Abstract] [Full-text]
29. Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination.
    Int J Radiat Oncol Biol Phys, 75(3): 683-7. [Abstract] [Full-text]
30. Urinary symptom flare in 712 125I prostate brachytherapy patients: long-term follow-up.
    Int J Radiat Oncol Biol Phys, 75(3): 649-55. [Abstract] [Full-text]
31. The influence of different IMRT techniques on the peripheral dose: a comparison between sMLM-IMRT and helical tomotherapy.
    Strahlenther Onkol, 185(10): 696-702. [Abstract] [Full-text]
32. Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters.
    Strahlenther Onkol, 185(10): 689-95. [Abstract] [Full-text]
33. Gamma knife radiosurgery for multiple sclerosis-related trigeminal neuralgia.
    Neurology, 73(14): 1149-54. [Abstract] [Full-text]
34. Reproductive outcomes in male childhood cancer survivors: a linked cancer-birth registry analysis.
    Arch Pediatr Adolesc Med, 163(10): 887-94. [Abstract] [Full-text]
35. Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis.
    Arch Pediatr Adolesc Med, 163(10): 879-86. [Abstract] [Full-text]
36. Evaluation of the late effects of CNS prophylactic treatment in childhood acute lymphoblastic leukemia (ALL) using magnetic resonance spectroscopy.
    Acta Neurochir Suppl, 106: 195-7. [Abstract] [Full-text]
37. The incidence of imaging abnormalities after stereotactic radiosurgery for cerebral arteriovenous and cavernous malformations.
    Acta Neurochir Suppl, 106: 187-90. [Abstract] [Full-text]
38. Surgical displacement of risk organs to improve stereotactic radiotherapy for liver tumors.
    J Surg Oncol, 100(6): 515-7. [Abstract] [Full-text]
39. Adrenal function testing in pediatric cancer survivors.
    Pediatr Blood Cancer, 53(7): 1302-7. [Abstract] [Full-text]
40. Successful treatment of locally advanced anaplastic thyroid carcinoma by chemotherapy and hyperfractionated radiotherapy.
    Auris Nasus Larynx, 36(6): 729-32. [Abstract] [Full-text]
41. Stereotactic radiosurgery for the treatment of lung neoplasm: experience in 100 consecutive patients.
    Ann Thorac Surg, 88(5): 1594-600; discussion 1600. [Abstract] [Full-text]
42. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
    Int J Radiat Oncol Biol Phys, 75(4): 1254-60. [Abstract] [Full-text]
43. Validation of temporal optimization effects for a single fraction of radiation in vitro.
    Int J Radiat Oncol Biol Phys, 75(4): 1240-6. [Abstract] [Full-text]
44. In vivo dosimetry with a linear MOSFET array to evaluate the urethra dose during permanent implant brachytherapy using iodine-125.
    Int J Radiat Oncol Biol Phys, 75(4): 1266-72. [Abstract] [Full-text]
45. Nonrandom intrafraction target motions and general strategy for correction of spine stereotactic body radiotherapy.
    Int J Radiat Oncol Biol Phys, 75(4): 1261-5. [Abstract] [Full-text]
46. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
    Int J Radiat Oncol Biol Phys, 75(4): 994-1002. [Abstract] [Full-text]
47. Pediatric craniospinal axis irradiation with helical tomotherapy: patient outcome and lack of acute pulmonary toxicity.
    Int J Radiat Oncol Biol Phys, 75(4): 1155-61. [Abstract] [Full-text]
48. Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer.
    Int J Radiat Oncol Biol Phys, 75(4): 1187-95. [Abstract] [Full-text]
49. Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma.
    Int J Radiat Oncol Biol Phys, 75(4): 1166-72. [Abstract] [Full-text]
50. Stereotactic body radiation therapy for liver tumors: impact of daily setup corrections and day-to-day anatomic variations on dose in target and organs at risk.
    Int J Radiat Oncol Biol Phys, 75(4): 1201-8. [Abstract] [Full-text]
51. Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors.
    Int J Radiat Oncol Biol Phys, 75(4): 1041-7. [Abstract] [Full-text]
52. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
    Int J Radiat Oncol Biol Phys, 75(4): 1013-20. [Abstract] [Full-text]
53. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Int J Radiat Oncol Biol Phys, 75(4): 1173-80. [Abstract] [Full-text]
54. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
    Int J Radiat Oncol Biol Phys, 75(4): 1071-8. [Abstract] [Full-text]
55. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
    Int J Radiat Oncol Biol Phys, 75(4): 1003-7. [Abstract] [Full-text]
56. Gamma Knife radiosurgery for brain metastases from primary breast cancer.
    Int J Radiat Oncol Biol Phys, 75(4): 1132-40. [Abstract] [Full-text]
57. Role of adaptive radiotherapy during concomitant chemoradiotherapy for lung cancer: analysis of data from a prospective clinical trial.
    Int J Radiat Oncol Biol Phys, 75(4): 1092-7. [Abstract] [Full-text]
58. Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.
    Int J Radiat Oncol Biol Phys, 75(4): 1125-31. [Abstract] [Full-text]

© 2004-2010 Radiotherapy Research Today. All Rights Reserved.